People in the News
Sirna Therapeutics said this week that Dennis Langer has been appointed to its board of directors.
Langer is currently managing partner at Phoenix IP Ventures, a Philadelphia-based venture capital firm. Prior to this position, he was president, North America, at Indian drugs firm Dr Reddy's Laboratories. Langer has also held positions at GlaxoSmithKline, SmithKline Beecham, and Eli Lilly.
Langer holds an MD from Georgetown University, a JD from Harvard Law School, and a BA in biology from Columbia University, Sirna said.
Â
Products & Services
Kreatech said this week that it has introduced RNA Ampulse Amplification and labeling kits for gene expression analysis.
According to the company, the kits combine Ambion's MessageAmp II aRNA amplification system technology with Kreatech's Universal Linkage system labeling technology.
The kits offer the ULS labeling molecule bound to a choice of fluorescent dye pairs that have been licensed by Kreatech, including the dyes from GE Healthcare, as well as a biotin kit which is ideal for use on Affymetrix's GeneChip, Kreatech said. In addition the RNA Ampulse kit also includes Kreatech's unique Kreapure columns to purify the labeled aRNA which insures effective removal of un-reacted ULS and higher recoveries of sample, the company added.